Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-002466

President & CEO sold 114,677 shares at an average $1.17 ($134,067)

From the SEC's structured data for this filing

Trades in this filing

Mohan Pankaj · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-01-03 Sale : show line 1 in the form −52,108 $1.18 $61,487 7,119,122 D
2018-01-04 Sale : show line 2 in the form −62,569 $1.16 $72,580 7,056,553 D
Open-market sales · 114,677 sh · avg $1.17 · $134,067
Loading xslF345X03/doc4.xml…